New drug targets 'Undruggable' cancer mutation in first human trial
NCT ID NCT07023731
Summary
This is the first study to test a new drug called ARV-806 in people with advanced solid tumors that have a specific KRAS G12D mutation. The main goals are to find a safe dose and see how the body processes the drug, while also looking for early signs that it can shrink tumors. The study is open to adults with advanced cancers who have tried standard treatments, with a special focus in later stages on pancreatic cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGPhoenix, Arizona, 85004, United States
-
Clinical Trial Site
RECRUITINGPhoenix, Arizona, 85054, United States
-
Clinical Trial Site
RECRUITINGNew Haven, Connecticut, 06510, United States
-
Clinical Trial Site
RECRUITINGTampa, Florida, 33612, United States
-
Clinical Trial Site
NOT_YET_RECRUITINGIndianapolis, Indiana, 46250, United States
-
Clinical Trial Site
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
Clinical Trial Site
RECRUITINGNew York, New York, 10032, United States
-
Clinical Trial Site
RECRUITINGNew York, New York, 10065, United States
-
Clinical Trial Site
RECRUITINGHuntersville, North Carolina, 28078, United States
-
Clinical Trial Site
RECRUITINGCleveland, Ohio, 44106, United States
-
Clinical Trial Site
RECRUITINGHouston, Texas, 77030-7009, United States
-
Clinical Trial Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
Clinical Trial Site
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Clinical Trial Site
RECRUITINGFairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.